Krsnaa Diagnostics Limited (KRSNAA.NS)
INR 910.0
(-0.9%)
INR 910.0
(-0.9%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 3.62 Billion INR | 111.57% |
| 2022 | 1.71 Billion INR | -17.49% |
| 2021 | 2.07 Billion INR | -44.34% |
| 2020 | 3.72 Billion INR | -54.94% |
| 2019 | 8.26 Billion INR | 34.7% |
| 2018 | 6.13 Billion INR | 93.54% |
| 2017 | 3.17 Billion INR | 217.46% |
| 2016 | 999.19 Million INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 4.53 Billion INR | 156.04% |
| 2024 Q1 | -8.09 Billion INR | -323.63% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 3.15 Billion INR | 0.0% |
| 2023 FY | 3.62 Billion INR | 111.57% |
| 2023 Q4 | 3.62 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2022 FY | 1.71 Billion INR | -17.49% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q4 | 1.71 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 2.18 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 2.07 Billion INR | -44.34% |
| 2021 Q4 | 2.07 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q2 | 2.32 Billion INR | 0.0% |
| 2020 Q4 | 3.74 Billion INR | 0.0% |
| 2020 FY | 3.72 Billion INR | -54.94% |
| 2019 Q4 | 8.26 Billion INR | 0.0% |
| 2019 FY | 8.26 Billion INR | 34.7% |
| 2018 FY | 6.13 Billion INR | 93.54% |
| 2017 FY | 3.17 Billion INR | 217.46% |
| 2016 FY | 999.19 Million INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Dr. Lal PathLabs Limited | 5.7 Billion INR | 36.539% |
| Metropolis Healthcare Limited | 4.55 Billion INR | 20.553% |
| Thyrocare Technologies Limited | 1.16 Billion INR | -211.493% |
| Vijaya Diagnostic Centre Limited | 3.22 Billion INR | -12.164% |
| Vimta Labs Limited | 803.54 Million INR | -350.645% |